Impact Factor 4.848 | CiteScore 3.5
More on impact ›
The Cancer Epidemiology and Prevention section accepts submissions focusing on the distribution, etiology, prevention, survivorship, and surveillance of oncological disease.
Manuscripts consisting solely of bioinformatics, computational analysis, or predictions of public databases, eg. SEER, which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) will not be accepted in this section.
Prospective authors should note that meta-analysis and descriptive studies must be based on rigorous statistical methods and bring new insights into the mechanisms of carcinogenesis.
The Cancer Epidemiology and Prevention section aims to publish rigorous research which gives new insights into the distribution, etiology, prevention, survivorship, and surveillance of cancer incidence. Our goal is to encourage interdisciplinary communication and collaborative research among basic scientists, epidemiologists, clinicians, and public health professionals in the field of oncology, to reduce cancer prevalence and mortality.
We are especially interested in research that has a practical application to the study of public health problems. The application of various risk factor assessments for the planning of clinical trials and preventive interventions is of particular interest. Descriptive and analytical epidemiology and biochemical, microbiological, molecular, genetic, clinical medicine, and histopathological approaches are likewise welcome.
Topics of interest include but are not limited to:
While we welcome meta-analyses and descriptive studies, these should be based on statistical methods or systematic reviews and should bring new insights into the mechanisms of carcinogenesis.
Indexed in: PubMed, PubMed Central (PMC), Scopus, Google Scholar, DOAJ, CrossRef, Chemical Abstracts Service (CAS), CLOCKSS
PMCID: all published articles receive a PMCID
Cancer Epidemiology and Prevention welcomes submissions of the following article types: Case Report, Clinical Trial, Correction, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, Specialty Grand Challenge, Systematic Review and Technology and Code.
All manuscripts must be submitted directly to the section Cancer Epidemiology and Prevention, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact firstname.lastname@example.org
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact email@example.com